Buprenorphine and Halofantrine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Halofantrine
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can affect your heart's rhythm. Buprenorphine (a pain or opioid-dependence medicine) and halofantrine (a malaria medicine) can each stretch out a part of your heartbeat called the QT interval. When you take them together, that effect can add up, which in rare cases can lead to a dangerous irregular heartbeat.
The good news is that this is a theoretical concern, meaning it is based on how the drugs work rather than lots of real-world reports. Please don't stop either medicine on your own. Instead, talk with your doctor or pharmacist. They can look at your heart health and decide the safest plan for you.
Mechanism: additive QT-interval prolongation. Both buprenorphine and halofantrine independently prolong the QT interval; combined use raises the risk of QTc prolongation and torsades de pointes. Neither is a prodrug relevant here; this is a pharmacodynamic (additive) interaction, not a metabolic one.
- Direction: increased cardiac (QT) effect
- Onset: unspecified
- Evidence: theoretical; combined magnitude not quantified
- Management: avoid concomitant use where possible. If used together, obtain baseline and follow-up ECG, correct electrolytes (K+, Mg2+), and screen for risk factors (bradycardia, CHF, baseline/congenital QT prolongation, digoxin therapy, recent AF cardioversion).
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
The simultaneous administration of buprenorphine alongside agents capable of prolonging the QT interval should be avoided342. It remains unknown what risk arises from pairing buprenorphine with additional QT prolonging medications. When buprenorphine is being prescribed to individuals who carry risk factors, including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, these findings should be factored into clinical decision making1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
What your care team may do:
- Try to avoid using these two together when another option is available.
- If both are needed, they may monitor you more closely, including an ECG to check your heart rhythm.
- Check and correct blood levels of potassium and magnesium, since low levels raise the risk.
- Review other risk factors such as a slow heart rate, heart failure, or a family history of heart-rhythm problems.
What you can do: Keep taking both exactly as prescribed unless told otherwise. Tell your pharmacist or doctor about any fainting, dizziness, or a pounding or irregular heartbeat right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Buprenorphine and Halofantrine together?
Buprenorphine and halofantrine can each prolong the QT interval, so combining them may add up and increase the risk of a dangerous heart rhythm; your care team will usually avoid the combination or monitor you closely (including an ECG and electrolytes). Do not stop either drug on your own, and report fainting or an irregular heartbeat promptly. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Buprenorphine and Halofantrine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Buprenorphine and Halofantrine interaction managed?
What your care team may do: Try to avoid using these two together when another option is available. If both are needed, they may monitor you more closely, including an ECG to check your heart rhythm. Check and correct blood levels of potassium and magnesium, since low levels raise the risk. Review other risk factors such as a slow heart rate, heart failure, or a family history of heart-rhythm prob… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Buprenorphine or Halofantrine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Halofantrine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist